Detalhe da pesquisa
1.
A stable hepatitis D virus-producing cell line for host target and drug discovery.
Antiviral Res
; 209: 105477, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36511319
2.
Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication.
J Med Chem
; 61(18): 8402-8416, 2018 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30153009
3.
Novel therapeutic approaches to simultaneously target rhinovirus infection and asthma/COPD pathogenesis.
F1000Res
; 6: 1860, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29123648
4.
Heterocyclic pharmacochemistry of new rhinovirus antiviral agents: A combined computational and experimental study.
Eur J Med Chem
; 140: 528-541, 2017 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28987610
5.
A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication.
J Med Chem
; 60(13): 5472-5492, 2017 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28581749
6.
VP1 crystal structure-guided exploration and optimization of 4,5-dimethoxybenzene-based inhibitors of rhinovirus 14 infection.
Eur J Med Chem
; 115: 453-62, 2016 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27049678
7.
Understanding the molecular mechanism of host-based statin resistance in hepatitis C virus replicon containing cells.
Biochem Pharmacol
; 96(3): 190-201, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26070251